← SynDRA
Gne-477
SynDRA canonical compound SYN0609344 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MTOR | PIK3CA |
| Mechanism of action | mtor inhibitor |
| Indication | renal cell carcinoma (rcc) |
| Disease area | oncology |
Cross-references
Synonyms
- 0E8LA9H0RY
- RefChem:922402
- GNE477
- MFCD20527726
- UNII-0E8LA9H0RY
- C21H28N8O3S2
- orb1303889
- SCHEMBL1180950
- SCHEMBL29367908
- GLXC-90033
- EX-A2063
- GNE 477?
- HRB75481
- BDBM50315907
- s6516
- AKOS027420931
- CS-3359
- NCGC00345851-01
- NCGC00345851-02
- NCGC00345851-04
- AC-31513
- AS-16287
- DA-33600
- HY-11042
- GNE-477; GNE477; GNE 477
- F85060
Look up Gne-477 in the interactive SynDRA portal →